Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/19/23 18:39 | 12/19/23 | CRDF | Health | BioPrd | Biological Products, (No Diag | Pace Gary W | CA | D | P | 41 | 1.37 | 0 | 30 | 4 | 698 | D | |||||||||||||||
11/29/22 16:11 | 11/25/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | Erlander Mark | CA | DO | CEO | P | 14 | 1.43 | 0 | 10 | 69 | 24 | D | ||||||||||||||
10/11/22 16:22 | 9/16/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | Armitage James O | CA | D | P | 20 | 1.56 | 0 | 13 | New | 13 | I | |||||||||||||||
9/20/22 18:08 | 9/19/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | White Lale | CA | D | P | 25 | 1.64 | 0 | 15 | 15 | 114 | I | |||||||||||||||
9/19/22 08:37 | 9/15/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | Tannenbaum Renee P | CA | D | P | 17 | 1.72 | 0 | 10 | New | 10 | D | |||||||||||||||
9/19/22 08:37 | 9/15/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | Pace Gary W | CA | D | P | 257 | 1.71 | 0 | 150 | 30 | 645 | D | |||||||||||||||
9/19/22 08:37 | 9/16/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | Levine James E. | CA | O | CFO | P | 47 | 1.56 | 0 | 30 | 100 | 60 | D | ||||||||||||||
7/6/22 16:10 | 7/5/22 | CRDF | Health | BioPrd | Biological Products, (No Diag | White Lale | CA | D | M.d | 75 | 2.60 | 0 | 29 | 41 | 99 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |